APRI (Apri), Drug Delivery System, Patient Friendly Drugs San Diego by Apricus Bio

HOME

ABOUT APRICUS

PRODUCTS

DEVELOPMENT PIPELINE

INVESTOR RELATIONS

CAREERS

Home

Investor Relations

SEC Filings - XBRL Content

Corporate Governance

Corporate Presentation

Social Media

Videos

Profile

Apricus Bio is a San Diego-based revenue-generating pharmaceutical company, with commercial products and a broad pipeline across numerous therapeutic classes including multiple approved and marketed drugs.

Apricus Biosciences Shareholder Notice: NASDAQ Closing Bell Event Featured on GLX-Television

Media & Events

March 23 2012
Apricus Biosciences Shareholder Notice: NASDAQ Closing Bell Event Featured on GLX-Television

March 08 2012
Apricus Biosciences Announces 2011 Year End Financial Results Conference Call

Upcoming Events

Apricus Biosciences to Present at the 11^th Annual JMP Securities Research Conference. Apricus Biosciences' presentation will take place on Wednesday, May 16, 2012 at 8:30am Pacific Time.

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Recent News

Date	Title
05/14/2012	Apricus Biosciences to Present at the 11th Annual JMP Securities Research Conference
05/11/2012	Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa™ for the Treatment of Onychomycosis
05/08/2012	Apricus Biosciences Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update